Ranitidine

Manufacturer: Shopko Stores Operating Co., LLC.
Effective date: 2012-08-29
Label type: HUMAN OTC DRUG LABEL
Version: 1
Source: legacy-cache
Hydrated at: 2026-08-02 01:45:49

Label at a glance#

ProductRanitidine

Active ingredientRANITIDINE HYDROCHLORIDE

Label structure14 sections

Indications and uses

relieves heartburn associated with acid indigestion and sour stomach prevents heartburn associated with acid indigestion and sour stomach brought on by certain foods and beverages

Dosage and administration

adults and children 12 years and older: to relieve symptoms, swallow 1 tablet with a glass of water to prevent symptoms, swallow 1 tablet with a glass of water 30 to 60 minutes before eating food or drinking beverages that cause heartburn can be used up to twice daily -do not take more than 2 tablets in 24 hours children under 12 years of age: ask a doctor

Contacts and useful links#

PhoneLabel contact1-877-753-3935

Label contents#

Full prescribing information#

Active ingredient (in each tablet)

OTC - ACTIVE INGREDIENT SECTION

Ranitidine 150 mg (as ranitidine hydrochloride 168 mg)

Purpose

OTC - PURPOSE SECTION

Acid reducer

Uses

INDICATIONS & USAGE SECTION

relieves heartburn associated with acid indigestion and sour stomach
prevents heartburn associated with acid indigestion and sour stomach brought on by certain foods and beverages

Warnings

WARNINGS SECTION

Allergy alert: Do not use if you are allergic to ranitidine or other acid reducers

Do not use

OTC - DO NOT USE SECTION

if you have trouble or pain swallowing food, vomiting with blood, or bloody or black stools. These may be signs of a serious condition. See your doctor.
with other acid reducers
if you have kidney disease, except under the advice and supervision of a doctor

Ask a doctor before use if you have:

OTC - ASK DOCTOR SECTION

frequent chest pain
unexplained weight loss
stomach pain
had heartburn over 3 months. This may be a sign of a more serious condition.
heartburn with lightheadedness, sweating or dizziness
chest pain or shoulder pain with shortness of breath; sweating; pain spreading to arms, neck or shoulders; or lightheadedness
frequent wheezing, particularly with heartburn
nausea or vomiting

Stop use and ask a doctor if

OTC - STOP USE SECTION

your heartburn continues or worsens
stomach pain continues
you need to take this product for more than 14 days

If pregnant or breast-feeding,

OTC - PREGNANCY OR BREAST FEEDING SECTION

ask a health care professional before use.

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

adults and children 12 years and older:
- to relieve symptoms, swallow 1 tablet with a glass of water
- to prevent symptoms, swallow 1 tablet with a glass of water 30 to 60 minutes before eating food or drinking beverages that cause heartburn
- can be used up to twice daily -do not take more than 2 tablets in 24 hours
children under 12 years of age: ask a doctor

Other information

OTHER SAFETY INFORMATION

do not use if printed foil under cap is torn or open
store at controlled room temperature 20°-25°C (68°-77°F)
avoid excessive heat or humidity
this product is sugar free
*This product is not manufactured or distributed by Glaxosmithkline Consumer Healthcare, owner of the registered trademark Zantac® 150

Inactive Ingredients

INACTIVE INGREDIENT SECTION

colloidal silicon dioxide, croscarmellose sodium, diethyl phthalate, FD&C yellow # 6, hypromellose, iron oxide red, magnesium stearate, microcrystalline cellulose and titanium dioxide.

Principal display panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

SHOPKO®

Maximum Strength HEARTBURN

Ranitidine Tablets, USP 150 mg

Acid Reducer

One tablet relieves: heartburn, acid indigestion & sour stomach

*Compare to Zantac 150® active ingredient

Read the directions, consumer information leaflet and warnings before use. Keep the carton. It contains important information.

Packaged by:

PL Developments

200 Hicks street

Westbury, NY 11590, USA

Questions or comments?

call toll free 1-877-753-3935

Product of INDIA

Product Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
37012-127-50	2024-05-22	C162847	48780-1	97449f38-d103-f6ea-e053-dbdaa90aa703	Drug Facts
37012-127-50	2019-11-13	C162847	48780-1	97449f38-d103-f6ea-e053-dbdaa90aa703	Drug Facts

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
RANITIDINE HYDROCHLORIDE	ACTIVE INGREDIENT	BK76465IHM	1
RANITIDINE	ACTIVE MOIETY	884KT10YB7	1
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	1
CROSCARMELLOSE SODIUM	INACTIVE INGREDIENT	M28OL1HH48	1
DIETHYL PHTHALATE	INACTIVE INGREDIENT	UF064M00AF	1
FD&C YELLOW NO. 6	INACTIVE INGREDIENT	H77VEI93A8	1
FERRIC OXIDE RED	INACTIVE INGREDIENT	1K09F3G675	1
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	1
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	1
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	1
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 11 matching rows.

Ranitidine
RANITIDINE HYDROCHLORIDE
SILICON DIOXIDE
CROSCARMELLOSE SODIUM
DIETHYL PHTHALATE
FD&C YELLOW NO. 6
HYPROMELLOSES
FERRIC OXIDE RED
MAGNESIUM STEARATE
CELLULOSE, MICROCRYSTALLINE
TITANIUM DIOXIDE

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
37012-127	37012-127-50

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 10 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
RANITIDINE HYDROCHLORIDE	BK76465IHM	ACTIM
SILICON DIOXIDE	ETJ7Z6XBU4	IACT
CROSCARMELLOSE SODIUM	M28OL1HH48	IACT
DIETHYL PHTHALATE	UF064M00AF	IACT
FD&C YELLOW NO. 6	H77VEI93A8	IACT
HYPROMELLOSES	3NXW29V3WO	IACT
FERRIC OXIDE RED	1K09F3G675	IACT
MAGNESIUM STEARATE	70097M6I30	IACT
CELLULOSE, MICROCRYSTALLINE	OP1R32D61U	IACT
TITANIUM DIOXIDE	15FIX9V2JP	IACT

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 5 · 269 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
TITANIUM DIOXIDE	TITANIUM DIOXIDE	15FIX9V2JP	TABLET, COATED / ORAL		49 mg	Exact identifier — unii candidate 40 equally ranked IID candidates
TITANIUM DIOXIDE	TITANIUM DIOXIDE	15FIX9V2JP	GEL / TOPICAL	0.06 %w/w		Exact identifier — unii candidate 40 equally ranked IID candidates
TITANIUM DIOXIDE	TITANIUM DIOXIDE	15FIX9V2JP	FILM, EXTENDED RELEASE / TRANSDERMAL	NA		Exact identifier — unii candidate 40 equally ranked IID candidates
TITANIUM DIOXIDE	TITANIUM DIOXIDE	15FIX9V2JP	POWDER, FOR SUSPENSION / ORAL		297 mg	Exact identifier — unii candidate 40 equally ranked IID candidates
HYPROMELLOSES	HYPROMELLOSE	3NXW29V3WO	CAPSULE, COATED PELLETS / ORAL	3.32 mg		Exact identifier — unii candidate 27 equally ranked IID candidates
FERRIC OXIDE RED	FERRIC OXIDE RED	1K09F3G675	TABLET, ORALLY DISINTEGRATING / ORAL		2 mg	Exact identifier — unii candidate 21 equally ranked IID candidates
TITANIUM DIOXIDE	TITANIUM DIOXIDE	15FIX9V2JP	CAPSULE, COATED PELLETS / ORAL	4.4 mg		Exact identifier — unii candidate 40 equally ranked IID candidates
TITANIUM DIOXIDE	TITANIUM DIOXIDE	15FIX9V2JP	CAPSULE, DELAYED RELEASE / ORAL		55 mg	Exact identifier — unii candidate 40 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	POWDER / RESPIRATORY (INHALATION)	0.13 mg		Exact identifier — unii candidate 39 equally ranked IID candidates
CROSCARMELLOSE SODIUM	CROSCARMELLOSE SODIUM	M28OL1HH48	TABLET, CHEWABLE / ORAL		216 mg	Exact identifier — unii candidate 22 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	CAPSULE, COATED / ORAL		3 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINE	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	TABLET, FOR SUSPENSION / ORAL		20100 mg	Exact identifier — unii candidate 28 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	GEL / DENTAL	19 %w/w		Exact identifier — unii candidate 49 equally ranked IID candidates
HYPROMELLOSES	HYPROMELLOSE	3NXW29V3WO	CREAM / TOPICAL	0.1 %w/w		Exact identifier — unii candidate 27 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	POWDER, FOR SOLUTION / ORAL		280 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINE	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	TABLET, DELAYED RELEASE PARTICLES / ORAL		580 mg	Exact identifier — unii candidate 28 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	TABLET, CHEWABLE, EXTENDED RELEASE / ORAL		9 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	GRANULE / ORAL	5000 mg		Exact identifier — unii candidate 49 equally ranked IID candidates
TITANIUM DIOXIDE	TITANIUM DIOXIDE	15FIX9V2JP	CAPSULE, LIQUID FILLED / ORAL		12 mg	Exact identifier — unii candidate 40 equally ranked IID candidates
FD&C YELLOW NO. 6	FD&C YELLOW NO. 6	H77VEI93A8	TABLET, CHEWABLE / ORAL	0.41 mg		Exact identifier — unii candidate 34 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	PELLET / ORAL		34 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
FD&C YELLOW NO. 6	FD&C YELLOW NO. 6	H77VEI93A8	CAPSULE / ORAL		7 mg	Exact identifier — unii candidate 34 equally ranked IID candidates
HYPROMELLOSES	HYPROMELLOSE	3NXW29V3WO	CAPSULE, DELAYED RELEASE / ORAL		105 mg	Exact identifier — unii candidate 27 equally ranked IID candidates
TITANIUM DIOXIDE	TITANIUM DIOXIDE	15FIX9V2JP	TABLET / ORAL		232 mg	Exact identifier — unii candidate 40 equally ranked IID candidates
DIETHYL PHTHALATE	DIETHYL PHTHALATE	UF064M00AF	TABLET, EXTENDED RELEASE / ORAL		43 mg	Exact identifier — unii candidate 9 equally ranked IID candidates
FERRIC OXIDE RED	FERRIC OXIDE RED	1K09F3G675	CAPSULE, DELAYED RELEASE / ORAL		14 mg	Exact identifier — unii candidate 21 equally ranked IID candidates
DIETHYL PHTHALATE	DIETHYL PHTHALATE	UF064M00AF	TABLET / ORAL		6 mg	Exact identifier — unii candidate 9 equally ranked IID candidates
TITANIUM DIOXIDE	TITANIUM DIOXIDE	15FIX9V2JP	SHAMPOO, SUSPENSION / TOPICAL	3 %w/v		Exact identifier — unii candidate 40 equally ranked IID candidates
FD&C YELLOW NO. 6	FD&C YELLOW NO. 6	H77VEI93A8	CAPSULE, COATED / ORAL	0.03 mg		Exact identifier — unii candidate 34 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	GRANULE, FOR SUSPENSION / ORAL		14 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	LOZENGE / TRANSMUCOSAL		100 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
TITANIUM DIOXIDE	TITANIUM DIOXIDE	15FIX9V2JP	INSERT, EXTENDED RELEASE / OPHTHALMIC	0.4 mg		Exact identifier — unii candidate 40 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINE	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	CAPSULE, COATED PELLETS / ORAL		456 mg	Exact identifier — unii candidate 28 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	SYSTEM / INTRAVITREAL	0.02 mg		Exact identifier — unii candidate 39 equally ranked IID candidates
HYPROMELLOSES	HYPROMELLOSE	3NXW29V3WO	SYRUP / ORAL		250 mg	Exact identifier — unii candidate 27 equally ranked IID candidates
FERRIC OXIDE RED	FERRIC OXIDE RED	1K09F3G675	CAPSULE, COATED / ORAL	0.12 mg		Exact identifier — unii candidate 21 equally ranked IID candidates
TITANIUM DIOXIDE	TITANIUM DIOXIDE	15FIX9V2JP	TABLET, FILM COATED, EXTENDED RELEASE / ORAL		11 mg	Exact identifier — unii candidate 40 equally ranked IID candidates
CROSCARMELLOSE SODIUM	CROSCARMELLOSE SODIUM	M28OL1HH48	TABLET, ORALLY DISINTEGRATING / ORAL		184 mg	Exact identifier — unii candidate 22 equally ranked IID candidates
FERRIC OXIDE RED	FERRIC OXIDE RED	1K09F3G675	POWDER, FOR SUSPENSION / ORAL		1 mg	Exact identifier — unii candidate 21 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINE	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	PELLET / ORAL		1140 mg	Exact identifier — unii candidate 28 equally ranked IID candidates
TITANIUM DIOXIDE	TITANIUM DIOXIDE	15FIX9V2JP	GRANULE, FOR SUSPENSION / ORAL		143 mg	Exact identifier — unii candidate 40 equally ranked IID candidates
TITANIUM DIOXIDE	TITANIUM DIOXIDE	15FIX9V2JP	FILM, SOLUBLE / ORAL		2 mg	Exact identifier — unii candidate 40 equally ranked IID candidates
FERRIC OXIDE RED	FERRIC OXIDE RED	1K09F3G675	SUSPENSION, EXTENDED RELEASE / ORAL	2.7 mg		Exact identifier — unii candidate 21 equally ranked IID candidates
CROSCARMELLOSE SODIUM	CROSCARMELLOSE SODIUM	M28OL1HH48	TABLET, DELAYED RELEASE PARTICLES / ORAL		64 mg	Exact identifier — unii candidate 22 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	LOZENGE / ORAL		120 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
FD&C YELLOW NO. 6	FD&C YELLOW NO. 6	H77VEI93A8	SOLUTION / ORAL	75.3 mg/15ml		Exact identifier — unii candidate 34 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINE	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	TABLET, FILM COATED, EXTENDED RELEASE / ORAL		615 mg	Exact identifier — unii candidate 28 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	TROCHE / ORAL		315 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINE	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	TABLET / ORAL		6184 mg	Exact identifier — unii candidate 28 equally ranked IID candidates
FD&C YELLOW NO. 6	FD&C YELLOW NO. 6	H77VEI93A8	POWDER, FOR SUSPENSION / ORAL		6 mg	Exact identifier — unii candidate 34 equally ranked IID candidates
DIETHYL PHTHALATE	DIETHYL PHTHALATE	UF064M00AF	TABLET, COATED / ORAL	2.8 mg		Exact identifier — unii candidate 9 equally ranked IID candidates
FERRIC OXIDE RED	FERRIC OXIDE RED	1K09F3G675	TABLET, FILM COATED / ORAL		3 mg	Exact identifier — unii candidate 21 equally ranked IID candidates
FD&C YELLOW NO. 6	FD&C YELLOW NO. 6	H77VEI93A8	SOAP / TOPICAL	0.2 %w/w		Exact identifier — unii candidate 34 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	FILM, SOLUBLE / ORAL		2 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
CROSCARMELLOSE SODIUM	CROSCARMELLOSE SODIUM	M28OL1HH48	INJECTION / INTRAMUSCULAR	1 %w/v		Exact identifier — unii candidate 22 equally ranked IID candidates
FD&C YELLOW NO. 6	FD&C YELLOW NO. 6	H77VEI93A8	CAPSULE, EXTENDED RELEASE / ORAL	4.59 mg		Exact identifier — unii candidate 34 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	TABLET, FILM COATED, EXTENDED RELEASE / ORAL		53 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	TABLET / SUBLINGUAL		10 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	TABLET / BUCCAL		3 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	CAPSULE, LIQUID FILLED / ORAL		106 mg	Exact identifier — unii candidate 49 equally ranked IID candidates

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A078653-001	RANITIDINE HYDROCHLORIDE	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL			2007-11-26

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	A078653-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2007-11-26	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A078653-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2007-11-26	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A078653-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2007-11-26	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A078653-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2007-11-26	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A078653-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2007-11-26	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A078653-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2007-11-26	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A078653-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2007-11-26	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A078653-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2007-11-26	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A078653-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2007-11-26	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A078653-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2007-11-26	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A078653-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2007-11-26	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A078653-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2007-11-26	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A078653-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2007-11-26	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A078653-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2007-11-26	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A078653-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2007-11-26	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A078653-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2007-11-26	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A078653-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2007-11-26	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A078653-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2007-11-26	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A078653-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2007-11-26	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A078653-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2007-11-26	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A078653-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2007-11-26	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A078653-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2007-11-26	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A078653-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2007-11-26	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A078653-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2007-11-26	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A078653-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2007-11-26	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A078653-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2007-11-26	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A078653-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2007-11-26	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A078653-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2007-11-26	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A078653-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2007-11-26	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A078653-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2007-11-26	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A078653-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2007-11-26	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A078653-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2007-11-26	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A078653-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2007-11-26	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A078653-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2007-11-26	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A078653-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2007-11-26	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A078653-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2007-11-26	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A078653-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2007-11-26	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A078653-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2007-11-26	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A078653-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2007-11-26	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A078653-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2007-11-26	`f41ea6bd6efb…`

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
85eeb5dc-2eb1-42e1-91ee-5a9278d678ac			c182e00b-9bb0-4af8-bc35-ee8eeda6ab18	2024-05-22	Warnings	Exact identifier spl set id: c182e00b-9bb0-4af8-bc35-ee8eeda6ab18

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.